© 2020-2025 Biopell TM
All Rights Reserved
Over 5,000 doctors and 200,000 patients are already using the Biopell System™
Back to top
Instructions
for use
Biopatid Pen — Injection Pen
Directions for use and dosage
The drug is administered subcutaneously into the abdomen, once a week, on the same day. Before the first injection, it is essential to dial 20 units on the pen-injector and push the plunger to the '0' mark until the first drop of the drug appears. If necessary, and if no drop appears, repeat the procedure.
Recommended dose
Pen-vial
20 mg / 2 ml
Single dose
from 25u=2.5 mg
Frequency
once a week
Administration time
morning/day
Injections per vial
8 injections (2.5 mg)
Vials per course
1-3 pen-vials
Composition
Cartridge (2 ml) contains:
Complex of synthetic essential and conditionally non-essential amino acids:
H-I-L-K-M-F-T-W-V-G-C
H-I-L-K-M-F-T-W-V-G-C
Water for Injection
Impact on Eating Behavior
Reduced impulsive overeating, decreased craving for fatty or sweet foods, improved emotional control over appetite.
Mechanism of Action
Biopatid is a dual agonist of GIP and GLP-1 receptors, which play a key role in metabolic regulation by reducing appetite, improving insulin sensitivity, slowing gastric emptying, and stabilizing glucose levels. Reviews of clinical studies have demonstrated that 72 weeks of Biopatid administration reduces weight depending on the concentration as follows:
Dosage
Effect
2.5 mg/week
weight reduction ~10%
5 mg/week
weight reduction ~15%
10 mg/week
weight reduction ~20%
15 mg/week
weight reduction ~22.5%
1 unit = 0.1 mg (1 click)
2.5 mg = 25 units
*90% of patients lost ≥5% of their weight
60% ≥20%
Side effects (most common)
In case of severe allergic reactions (facial swelling, difficulty breathing), seek immediate medical attention!
01
Nausea, vomiting
02
Diarrhea or constipation
03
Decreased appetite
04
Hypoglycemia (especially when taken concurrently with insulin or sulfonylurea).
Interactions with other medicinal products
01
Enhances the effect of hypoglycemic agents
02
May alter the absorption rate of oral medications
Shelf life
2 years. Do not use after the date indicated on the package.
Indications for use
01
Weight management in obesity (as part of the Biopell System weight loss program, as prescribed by a doctor)
02
Type 2 diabetes mellitus – as an additional therapy to diet and exercise.
Contraindications
01
Hypersensitivity to any component of the drug
02
Pregnancy and lactation
03
Children under 18 years of age
04
Severe hepatic or renal insufficiency
Biopatid Manufacturing Process Highlights
Biopatid is manufactured from a high-quality pharmaceutical substance that undergoes a multi-stage purification process with a high degree of purity. To ensure the stability and microbiological safety of the product, a specially selected stabilizing medium is used, which maintains the sterility of the solution throughout its entire shelf life. The entire manufacturing process is carried out: under controlled cold conditions, using 0.22 µm PES membrane filters, and in compliance with GMP standards at every stage. This approach ensures a high level of quality, sterility, and safety, which is crucial for the clinical application of the product in medical practice.
Special Considerations for Use
01
Blood glucose level monitoring is required
02
Patients with chronic diseases — consult a doctor before starting therapy
03
Alcohol consumption is not recommended during treatment
04
Use with caution in case of gastrointestinal dysfunction
Storage and transportation conditions
01
Store at 2–8°C (in the refrigerator).
02
Do not freeze
03
After opening, store at 2–8°C (in the refrigerator), noting a partial decrease in the concentration of the active substance.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.